title: Is the literature inconclusive about the harm of HES? We are not sure.
authors.affiliation: Division of Cellular and Molecular Medicine, Clinical Department and Laboratory of Intensive Care Medicine, KU Leuven University, Herestraat 49, 3000, Louvain, Belgium. miet.schetz@scarlet.be.
authors.forename: Miet
authors.identifier: http://orcid.org/0000-0001-5776-4827
authors.initials: M
authors.lastname: Schetz
authors.affiliation: Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Shaw
authors.affiliation: Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
authors.forename: Jean-Louis
authors.initials: JL
authors.lastname: Vincent
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced; D016638:Critical Illness / Q000401:mortality / Q000628:therapy; D000077324:Crystalloid Solutions; D005440:Fluid Therapy / Q000379:methods; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000009:adverse effects* / Q000494:pharmacology; D007362:Intensive Care Units; D007552:Isotonic Solutions / Q000008:administration & dosage; D010952:Plasma Substitutes / Q000009:adverse effects* / Q000494:pharmacology; D016032:Randomized Controlled Trials as Topic
chemical_list: D000077324:Crystalloid Solutions; D006895:Hydroxyethyl Starch Derivatives; D007552:Isotonic Solutions; D010952:Plasma Substitutes